Accelero Reports 2020 Financial Results and 2021 Forecast
Accelero Bioanalytics GmbH (“Accelero”) announced key figures for the fiscal year 2020 in Germany´s Federal Gazette.
Accelero Receives EU Eurostars Funding Supporting a Gene Therapy for the Treatment of Lypodystrophy
Accelero Bioanalytics GmbH (“Accelero”) is awarded EUR 136,500 in project grants to support research and development of a gene therapy targeting lypodystrophy.
